The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Intravitreal Injectable Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2028
Synopsis
The Intravitreal Injectable market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Intravitreal Injectable market size is estimated to be worth US$ 14950 million in 2021 and is forecast to a readjusted size of USD 23690 million by 2028 with a CAGR of 6.8% during review period. Macular Degeneration accounting for % of the Intravitreal Injectable global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Anti-VEGF segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Intravitreal Injectable include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, and Kanghong Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Intravitreal Injectable market is split by Drug and by Disease. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Drug and by Disease in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Drug, covers
Anti-VEGF
Steroids
Others
Market segment by Disease can be divided into
Macular Degeneration
Macular Edema
Uveitis
Retinal Vein Occlusion
Others
The key market players for global Intravitreal Injectable market are listed below:
Regeneron Pharmaceuticals (Eylea)
Allergan
EyePoint Pharmaceuticals
Genentech
Kanghong Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intravitreal Injectable product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Intravitreal Injectable, with price, sales, revenue and global market share of Intravitreal Injectable from 2019 to 2022.
Chapter 3, the Intravitreal Injectable competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intravitreal Injectable breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Drug and application, with sales market share and growth rate by drug, disease, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Intravitreal Injectable market forecast, by regions, drug and disease, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Intravitreal Injectable.
Chapter 13, 14, and 15, to describe Intravitreal Injectable sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
The Intravitreal Injectable market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Intravitreal Injectable market size is estimated to be worth US$ 14950 million in 2021 and is forecast to a readjusted size of USD 23690 million by 2028 with a CAGR of 6.8% during review period. Macular Degeneration accounting for % of the Intravitreal Injectable global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Anti-VEGF segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Intravitreal Injectable include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, and Kanghong Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Intravitreal Injectable market is split by Drug and by Disease. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Drug and by Disease in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Drug, covers
Anti-VEGF
Steroids
Others
Market segment by Disease can be divided into
Macular Degeneration
Macular Edema
Uveitis
Retinal Vein Occlusion
Others
The key market players for global Intravitreal Injectable market are listed below:
Regeneron Pharmaceuticals (Eylea)
Allergan
EyePoint Pharmaceuticals
Genentech
Kanghong Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intravitreal Injectable product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Intravitreal Injectable, with price, sales, revenue and global market share of Intravitreal Injectable from 2019 to 2022.
Chapter 3, the Intravitreal Injectable competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intravitreal Injectable breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Drug and application, with sales market share and growth rate by drug, disease, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Intravitreal Injectable market forecast, by regions, drug and disease, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Intravitreal Injectable.
Chapter 13, 14, and 15, to describe Intravitreal Injectable sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Intravitreal Injectable Introduction
1.2 Market Analysis by Drug
1.2.1 Overview: Global Intravitreal Injectable Revenue by Drug: 2017 Versus 2021 Versus 2028
1.2.2 Anti-VEGF
1.2.3 Steroids
1.2.4 Others
1.3 Market Analysis by Disease
1.3.1 Overview: Global Intravitreal Injectable Revenue by Disease: 2017 Versus 2021 Versus 2028
1.3.2 Macular Degeneration
1.3.3 Macular Edema
1.3.4 Uveitis
1.3.5 Retinal Vein Occlusion
1.3.6 Others
1.4 Global Intravitreal Injectable Market Size & Forecast
1.4.1 Global Intravitreal Injectable Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Intravitreal Injectable Sales in Volume (2017-2028)
1.4.3 Global Intravitreal Injectable Price (2017-2028)
1.5 Global Intravitreal Injectable Production Capacity Analysis
1.5.1 Global Intravitreal Injectable Total Production Capacity (2017-2028)
1.5.2 Global Intravitreal Injectable Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Intravitreal Injectable Market Drivers
1.6.2 Intravitreal Injectable Market Restraints
1.6.3 Intravitreal Injectable Trends Analysis
2 Manufacturers Profiles
2.1 Regeneron Pharmaceuticals (Eylea)
2.1.1 Regeneron Pharmaceuticals (Eylea) Details
2.1.2 Regeneron Pharmaceuticals (Eylea) Major Business
2.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product and Services
2.1.4 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Allergan
2.2.1 Allergan Details
2.2.2 Allergan Major Business
2.2.3 Allergan Intravitreal Injectable Product and Services
2.2.4 Allergan Intravitreal Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 EyePoint Pharmaceuticals
2.3.1 EyePoint Pharmaceuticals Details
2.3.2 EyePoint Pharmaceuticals Major Business
2.3.3 EyePoint Pharmaceuticals Intravitreal Injectable Product and Services
2.3.4 EyePoint Pharmaceuticals Intravitreal Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Genentech
2.4.1 Genentech Details
2.4.2 Genentech Major Business
2.4.3 Genentech Intravitreal Injectable Product and Services
2.4.4 Genentech Intravitreal Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Kanghong Pharmaceutical
2.5.1 Kanghong Pharmaceutical Details
2.5.2 Kanghong Pharmaceutical Major Business
2.5.3 Kanghong Pharmaceutical Intravitreal Injectable Product and Services
2.5.4 Kanghong Pharmaceutical Intravitreal Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Intravitreal Injectable Breakdown Data by Manufacturer
3.1 Global Intravitreal Injectable Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Intravitreal Injectable Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Intravitreal Injectable
3.4 Market Concentration Rate
3.4.1 Top 3 Intravitreal Injectable Manufacturer Market Share in 2021
3.4.2 Top 6 Intravitreal Injectable Manufacturer Market Share in 2021
3.5 Global Intravitreal Injectable Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Intravitreal Injectable Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Intravitreal Injectable Market Size by Region
4.1.1 Global Intravitreal Injectable Sales in Volume by Region (2017-2028)
4.1.2 Global Intravitreal Injectable Revenue by Region (2017-2028)
4.2 North America Intravitreal Injectable Revenue (2017-2028)
4.3 Europe Intravitreal Injectable Revenue (2017-2028)
4.4 Asia-Pacific Intravitreal Injectable Revenue (2017-2028)
4.5 South America Intravitreal Injectable Revenue (2017-2028)
4.6 Middle East and Africa Intravitreal Injectable Revenue (2017-2028)
5 Market Segment by Drug
5.1 Global Intravitreal Injectable Sales in Volume by Drug (2017-2028)
5.2 Global Intravitreal Injectable Revenue by Drug (2017-2028)
5.3 Global Intravitreal Injectable Price by Drug (2017-2028)
6 Market Segment by Disease
6.1 Global Intravitreal Injectable Sales in Volume by Disease (2017-2028)
6.2 Global Intravitreal Injectable Revenue by Disease (2017-2028)
6.3 Global Intravitreal Injectable Price by Disease (2017-2028)
7 North America by Country, by Drug, and by Disease
7.1 North America Intravitreal Injectable Sales by Drug (2017-2028)
7.2 North America Intravitreal Injectable Sales by Disease (2017-2028)
7.3 North America Intravitreal Injectable Market Size by Country
7.3.1 North America Intravitreal Injectable Sales in Volume by Country (2017-2028)
7.3.2 North America Intravitreal Injectable Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Drug, and by Disease
8.1 Europe Intravitreal Injectable Sales by Drug (2017-2028)
8.2 Europe Intravitreal Injectable Sales by Disease (2017-2028)
8.3 Europe Intravitreal Injectable Market Size by Country
8.3.1 Europe Intravitreal Injectable Sales in Volume by Country (2017-2028)
8.3.2 Europe Intravitreal Injectable Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Drug, and by Disease
9.1 Asia-Pacific Intravitreal Injectable Sales by Drug (2017-2028)
9.2 Asia-Pacific Intravitreal Injectable Sales by Disease (2017-2028)
9.3 Asia-Pacific Intravitreal Injectable Market Size by Region
9.3.1 Asia-Pacific Intravitreal Injectable Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Intravitreal Injectable Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Drug, and by Disease
10.1 South America Intravitreal Injectable Sales by Drug (2017-2028)
10.2 South America Intravitreal Injectable Sales by Disease (2017-2028)
10.3 South America Intravitreal Injectable Market Size by Country
10.3.1 South America Intravitreal Injectable Sales in Volume by Country (2017-2028)
10.3.2 South America Intravitreal Injectable Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Drug, and by Disease
11.1 Middle East & Africa Intravitreal Injectable Sales by Drug (2017-2028)
11.2 Middle East & Africa Intravitreal Injectable Sales by Disease (2017-2028)
11.3 Middle East & Africa Intravitreal Injectable Market Size by Country
11.3.1 Middle East & Africa Intravitreal Injectable Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Intravitreal Injectable Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Intravitreal Injectable and Key Manufacturers
12.2 Manufacturing Costs Percentage of Intravitreal Injectable
12.3 Intravitreal Injectable Production Process
12.4 Intravitreal Injectable Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Intravitreal Injectable Typical Distributors
13.3 Intravitreal Injectable Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global Intravitreal Injectable Revenue by Drug, (USD Million), 2017 & 2021 & 2028
Table 2. Global Intravitreal Injectable Revenue by Disease, (USD Million), 2017 & 2021 & 2028
Table 3. Regeneron Pharmaceuticals (Eylea) Basic Information, Manufacturing Base and Competitors
Table 4. Regeneron Pharmaceuticals (Eylea) Major Business
Table 5. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product and Services
Table 6. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Allergan Basic Information, Manufacturing Base and Competitors
Table 8. Allergan Major Business
Table 9. Allergan Intravitreal Injectable Product and Services
Table 10. Allergan Intravitreal Injectable Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. EyePoint Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. EyePoint Pharmaceuticals Major Business
Table 13. EyePoint Pharmaceuticals Intravitreal Injectable Product and Services
Table 14. EyePoint Pharmaceuticals Intravitreal Injectable Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Genentech Basic Information, Manufacturing Base and Competitors
Table 16. Genentech Major Business
Table 17. Genentech Intravitreal Injectable Product and Services
Table 18. Genentech Intravitreal Injectable Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Kanghong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Kanghong Pharmaceutical Major Business
Table 21. Kanghong Pharmaceutical Intravitreal Injectable Product and Services
Table 22. Kanghong Pharmaceutical Intravitreal Injectable Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Global Intravitreal Injectable Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 24. Global Intravitreal Injectable Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 25. Market Position of Manufacturers in Intravitreal Injectable, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 26. Global Intravitreal Injectable Production Capacity by Company, (K Units): 2020 VS 2021
Table 27. Head Office and Intravitreal Injectable Production Site of Key Manufacturer
Table 28. Intravitreal Injectable New Entrant and Capacity Expansion Plans
Table 29. Intravitreal Injectable Mergers & Acquisitions in the Past Five Years
Table 30. Global Intravitreal Injectable Sales by Region (2017-2022) & (K Units)
Table 31. Global Intravitreal Injectable Sales by Region (2023-2028) & (K Units)
Table 32. Global Intravitreal Injectable Revenue by Region (2017-2022) & (USD Million)
Table 33. Global Intravitreal Injectable Revenue by Region (2023-2028) & (USD Million)
Table 34. Global Intravitreal Injectable Sales by Drug (2017-2022) & (K Units)
Table 35. Global Intravitreal Injectable Sales by Drug (2023-2028) & (K Units)
Table 36. Global Intravitreal Injectable Revenue by Drug (2017-2022) & (USD Million)
Table 37. Global Intravitreal Injectable Revenue by Drug (2023-2028) & (USD Million)
Table 38. Global Intravitreal Injectable Price by Drug (2017-2022) & (US$/Unit)
Table 39. Global Intravitreal Injectable Price by Drug (2023-2028) & (US$/Unit)
Table 40. Global Intravitreal Injectable Sales by Disease (2017-2022) & (K Units)
Table 41. Global Intravitreal Injectable Sales by Disease (2023-2028) & (K Units)
Table 42. Global Intravitreal Injectable Revenue by Disease (2017-2022) & (USD Million)
Table 43. Global Intravitreal Injectable Revenue by Disease (2023-2028) & (USD Million)
Table 44. Global Intravitreal Injectable Price by Disease (2017-2022) & (US$/Unit)
Table 45. Global Intravitreal Injectable Price by Disease (2023-2028) & (US$/Unit)
Table 46. North America Intravitreal Injectable Sales by Country (2017-2022) & (K Units)
Table 47. North America Intravitreal Injectable Sales by Country (2023-2028) & (K Units)
Table 48. North America Intravitreal Injectable Revenue by Country (2017-2022) & (USD Million)
Table 49. North America Intravitreal Injectable Revenue by Country (2023-2028) & (USD Million)
Table 50. North America Intravitreal Injectable Sales by Drug (2017-2022) & (K Units)
Table 51. North America Intravitreal Injectable Sales by Drug (2023-2028) & (K Units)
Table 52. North America Intravitreal Injectable Sales by Disease (2017-2022) & (K Units)
Table 53. North America Intravitreal Injectable Sales by Disease (2023-2028) & (K Units)
Table 54. Europe Intravitreal Injectable Sales by Country (2017-2022) & (K Units)
Table 55. Europe Intravitreal Injectable Sales by Country (2023-2028) & (K Units)
Table 56. Europe Intravitreal Injectable Revenue by Country (2017-2022) & (USD Million)
Table 57. Europe Intravitreal Injectable Revenue by Country (2023-2028) & (USD Million)
Table 58. Europe Intravitreal Injectable Sales by Drug (2017-2022) & (K Units)
Table 59. Europe Intravitreal Injectable Sales by Drug (2023-2028) & (K Units)
Table 60. Europe Intravitreal Injectable Sales by Disease (2017-2022) & (K Units)
Table 61. Europe Intravitreal Injectable Sales by Disease (2023-2028) & (K Units)
Table 62. Asia-Pacific Intravitreal Injectable Sales by Region (2017-2022) & (K Units)
Table 63. Asia-Pacific Intravitreal Injectable Sales by Region (2023-2028) & (K Units)
Table 64. Asia-Pacific Intravitreal Injectable Revenue by Region (2017-2022) & (USD Million)
Table 65. Asia-Pacific Intravitreal Injectable Revenue by Region (2023-2028) & (USD Million)
Table 66. Asia-Pacific Intravitreal Injectable Sales by Drug (2017-2022) & (K Units)
Table 67. Asia-Pacific Intravitreal Injectable Sales by Drug (2023-2028) & (K Units)
Table 68. Asia-Pacific Intravitreal Injectable Sales by Disease (2017-2022) & (K Units)
Table 69. Asia-Pacific Intravitreal Injectable Sales by Disease (2023-2028) & (K Units)
Table 70. South America Intravitreal Injectable Sales by Country (2017-2022) & (K Units)
Table 71. South America Intravitreal Injectable Sales by Country (2023-2028) & (K Units)
Table 72. South America Intravitreal Injectable Revenue by Country (2017-2022) & (USD Million)
Table 73. South America Intravitreal Injectable Revenue by Country (2023-2028) & (USD Million)
Table 74. South America Intravitreal Injectable Sales by Drug (2017-2022) & (K Units)
Table 75. South America Intravitreal Injectable Sales by Drug (2023-2028) & (K Units)
Table 76. South America Intravitreal Injectable Sales by Disease (2017-2022) & (K Units)
Table 77. South America Intravitreal Injectable Sales by Disease (2023-2028) & (K Units)
Table 78. Middle East & Africa Intravitreal Injectable Sales by Region (2017-2022) & (K Units)
Table 79. Middle East & Africa Intravitreal Injectable Sales by Region (2023-2028) & (K Units)
Table 80. Middle East & Africa Intravitreal Injectable Revenue by Region (2017-2022) & (USD Million)
Table 81. Middle East & Africa Intravitreal Injectable Revenue by Region (2023-2028) & (USD Million)
Table 82. Middle East & Africa Intravitreal Injectable Sales by Drug (2017-2022) & (K Units)
Table 83. Middle East & Africa Intravitreal Injectable Sales by Drug (2023-2028) & (K Units)
Table 84. Middle East & Africa Intravitreal Injectable Sales by Disease (2017-2022) & (K Units)
Table 85. Middle East & Africa Intravitreal Injectable Sales by Disease (2023-2028) & (K Units)
Table 86. Intravitreal Injectable Raw Material
Table 87. Key Manufacturers of Intravitreal Injectable Raw Materials
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. Intravitreal Injectable Typical Distributors
Table 91. Intravitreal Injectable Typical Customers
List of Figures
Figure 1. Intravitreal Injectable Picture
Figure 2. Global Intravitreal Injectable Revenue Market Share by Drug in 2021
Figure 3. Anti-VEGF
Figure 4. Steroids
Figure 5. Others
Figure 6. Global Intravitreal Injectable Revenue Market Share by Disease in 2021
Figure 7. Macular Degeneration
Figure 8. Macular Edema
Figure 9. Uveitis
Figure 10. Retinal Vein Occlusion
Figure 11. Others
Figure 12. Global Intravitreal Injectable Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global Intravitreal Injectable Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Intravitreal Injectable Sales (2017-2028) & (K Units)
Figure 15. Global Intravitreal Injectable Price (2017-2028) & (US$/Unit)
Figure 16. Global Intravitreal Injectable Production Capacity (2017-2028) & (K Units)
Figure 17. Global Intravitreal Injectable Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Intravitreal Injectable Market Drivers
Figure 19. Intravitreal Injectable Market Restraints
Figure 20. Intravitreal Injectable Market Trends
Figure 21. Global Intravitreal Injectable Sales Market Share by Manufacturer in 2021
Figure 22. Global Intravitreal Injectable Revenue Market Share by Manufacturer in 2021
Figure 23. Intravitreal Injectable Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Intravitreal Injectable Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Intravitreal Injectable Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Intravitreal Injectable Sales Market Share by Region (2017-2028)
Figure 27. Global Intravitreal Injectable Revenue Market Share by Region (2017-2028)
Figure 28. North America Intravitreal Injectable Revenue (2017-2028) & (USD Million)
Figure 29. Europe Intravitreal Injectable Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Intravitreal Injectable Revenue (2017-2028) & (USD Million)
Figure 31. South America Intravitreal Injectable Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Intravitreal Injectable Revenue (2017-2028) & (USD Million)
Figure 33. Global Intravitreal Injectable Sales Market Share by Drug (2017-2028)
Figure 34. Global Intravitreal Injectable Revenue Market Share by Drug (2017-2028)
Figure 35. Global Intravitreal Injectable Price by Drug (2017-2028) & (US$/Unit)
Figure 36. Global Intravitreal Injectable Sales Market Share by Disease (2017-2028)
Figure 37. Global Intravitreal Injectable Revenue Market Share by Disease (2017-2028)
Figure 38. Global Intravitreal Injectable Price by Disease (2017-2028) & (US$/Unit)
Figure 39. North America Intravitreal Injectable Sales Market Share by Drug (2017-2028)
Figure 40. North America Intravitreal Injectable Sales Market Share by Disease (2017-2028)
Figure 41. North America Intravitreal Injectable Sales Market Share by Country (2017-2028)
Figure 42. North America Intravitreal Injectable Revenue Market Share by Country (2017-2028)
Figure 43. United States Intravitreal Injectable Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Intravitreal Injectable Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Intravitreal Injectable Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Intravitreal Injectable Sales Market Share by Drug (2017-2028)
Figure 47. Europe Intravitreal Injectable Sales Market Share by Disease (2017-2028)
Figure 48. Europe Intravitreal Injectable Sales Market Share by Country (2017-2028)
Figure 49. Europe Intravitreal Injectable Revenue Market Share by Country (2017-2028)
Figure 50. Germany Intravitreal Injectable Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Intravitreal Injectable Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Intravitreal Injectable Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Intravitreal Injectable Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Intravitreal Injectable Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Intravitreal Injectable Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Intravitreal Injectable Sales Market Share by Disease (2017-2028)
Figure 57. Asia-Pacific Intravitreal Injectable Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Intravitreal Injectable Revenue Market Share by Region (2017-2028)
Figure 59. China Intravitreal Injectable Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Intravitreal Injectable Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Intravitreal Injectable Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Intravitreal Injectable Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Intravitreal Injectable Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Intravitreal Injectable Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Intravitreal Injectable Sales Market Share by Drug (2017-2028)
Figure 66. South America Intravitreal Injectable Sales Market Share by Disease (2017-2028)
Figure 67. South America Intravitreal Injectable Sales Market Share by Country (2017-2028)
Figure 68. South America Intravitreal Injectable Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Intravitreal Injectable Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Intravitreal Injectable Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Intravitreal Injectable Sales Market Share by Drug (2017-2028)
Figure 72. Middle East & Africa Intravitreal Injectable Sales Market Share by Disease (2017-2028)
Figure 73. Middle East & Africa Intravitreal Injectable Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Intravitreal Injectable Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Intravitreal Injectable Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Intravitreal Injectable Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Intravitreal Injectable Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Intravitreal Injectable Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Intravitreal Injectable in 2021
Figure 80. Manufacturing Process Analysis of Intravitreal Injectable
Figure 81. Intravitreal Injectable Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
